Department of eyeSmart EMR & AEye, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Center for Ocular Regeneration (CORE), L V Prasad Eye Institute, Hyderabad, Telangana, India
Br J Ophthalmol. 2021 Jan;105(1):17-21. doi: 10.1136/bjophthalmol-2019-315361. Epub 2020 Mar 18.
To describe the indications and prognosis for keratoplasty in eyes with severe visual impairment and blindness due to corneal diseases in India.
This hospital-based cross-sectional study included 1 057 215 new patients presenting to a multitier ophthalmology network from 2016 to 2018. All patients with a central corneal pathology and best corrected visual acuity of less than 20/200 in the affected eye(s) were identified as cases and grouped according to laterality. The main outcome measure was the prognosis for keratoplasty, based on the surgical indication.
A total of 28 824 (2.73%) patients were identified with severe visual impairment or blindness due to corneal diseases; of which, 22 582 (78.3%) had unilateral and 6242 (21.7%) had bilateral affliction. Overall, 85% of the corneal pathologies were due to avoidable causes, which accounted for 97% and 63% of the unilateral and bilateral cases, respectively (p<0.0001). The most common aetiologies were microbial keratitis (27.2%) and corneal opacification (25.5%) in unilateral cases; and corneal opacification (38.2%) and ectasias (14.5%) in bilateral cases. Overall, 60.1% of affected eyes carried a fair to poor prognosis for keratoplasty. However, while in unilateral cases only 29.9% of eyes carried good to excellent prognosis for keratoplasty, in bilateral cases, 58% of eyes carried good to excellent prognosis for keratoplasty (p<0.0001).
The indications and prognosis for keratoplasty varied greatly based on whether the affliction was unilateral or bilateral. Most of the eyes affected by corneal visual impairment or blindness, however, carried an unfavourable prognosis for keratoplasty.
描述印度因角膜疾病导致严重视力损害和失明的患者行角膜移植术的适应证和预后。
本研究为医院横断面研究,纳入了 2016 年至 2018 年期间某多层级眼科网络中就诊的 1057215 例新患者。所有具有中央角膜病变且患眼(或双眼)最佳矫正视力<20/200 的患者被确定为病例,并根据病变的侧别进行分组。主要结局指标是基于手术适应证的角膜移植术预后。
共 28824 例(2.73%)患者因角膜疾病导致严重视力损害或失明;其中 22582 例(78.3%)为单侧,6242 例(21.7%)为双侧。总体而言,85%的角膜病变是由可避免的原因引起的,其中 97%和 63%的单侧和双侧病例分别由可避免的原因引起(p<0.0001)。单侧最常见的病因是微生物性角膜炎(27.2%)和角膜混浊(25.5%);双侧最常见的病因是角膜混浊(38.2%)和扩张(14.5%)。总体而言,60.1%的患眼行角膜移植术的预后为差到尚可。然而,单侧病例中仅有 29.9%的患眼行角膜移植术的预后为好到极好,而双侧病例中,58%的患眼行角膜移植术的预后为好到极好(p<0.0001)。
单侧或双侧角膜病变的角膜移植术适应证和预后差异很大。然而,大多数患有角膜视力损害或失明的眼行角膜移植术的预后较差。